Pfizer and BioNTech have lost their appeal against a ruling that they infringed on Moderna's patent for COVID-19 vaccine technology, allowing Moderna to seek damages for post-March...
Moderna Inc. plans to cut 10% of its global workforce to reduce operating expenses, targeting under 5,000 employees by year's end. This decision follows a $1 billion net loss in Q1...
Moderna reports a $1 billion net loss in Q1 2025 due to decreased COVID-19 vaccine sales, with Spikevax® generating $84 million. CEO Stephane Bancel remains optimistic about future...
Moderna reports a $1 billion net loss in Q1 2025, with revenues dropping to $108 million. The decline is attributed to reduced COVID-19 vaccine sales, but the company remains hopef...
The US Attorney's office is investigating claims that Pfizer delayed announcing its COVID-19 vaccine success until after the 2020 election. Former employee Phil Dormitzer's alleged...
